Daunorubicin (Liposomal)
Records for this ingredient, by country (identity only).
ATC L01DB02 · 2 markets · 4 records
GB 2 records · 2 shown of 2
Only this ingredient
- 50 mg/25 mLinjectionDaunoXome 50mg/25ml concentrate for solution for infusion vials
Combination products containing this ingredient
- 44 mg per mL / per unit basis not statedinjection CombinationCytarabine (Liposomal) 100 mg + Daunorubicin (Liposomal) 44 mgVyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials
AU 2 records · 2 shown of 2
Only this ingredient
- 20 mg per mL / per unit basis not statedinjectionPfizer (Australia) DAUNORUBICIN (as hydrochloride) 20mg/10mL injection vial
Combination products containing this ingredient
- 44 mg per mL / per unit basis not statedinjection CombinationCytarabine (Liposomal) 100 mg + Daunorubicin (Liposomal) 44 mgVYXEOS daunorubicin (as hydrochloride) 44 mg and cytarabine 100 mg powder for injection vial
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.